Tripadvisor: Why I'm Underwriting Tail Risk At $7.00 To Harvest 21% Annualized Yield

The strategy utilizes selling deep OTM cash-secured puts ($7.00 strike) to target a 21%+ annualized yield with extreme ...

Snowflake: The Risk/Reward Finally Favors The Bulls

Snowflake (SNOW) gets a Buy as AI-driven demand boosts bookings and valuation looks attractive. Read here for an investment ...
Kalkine Media

HEICO Valuation Check Puts Russell 1000 Index In Focus

HEICO’s valuation checks show a mixed picture as cash flow strength and earnings multiples create different market signals.

Birchcliff Energy Ltd. Announces Strong Q1 2026 Results and Declares Q2 2026 Dividend

Birchcliff Energy Ltd. ("Birchcliff" or the "Corporation") (TSX: BIR) is pleased to announce its Q1 2026 financial and operational results. Birchcliff ...

Is It Too Late To Consider Texas Instruments (TXN) After Its Rapid Share Price Surge

If you are asking whether Texas Instruments at US$295.17 is still a good deal or already pricing in a lot of optimism, you ...

Hot inflation data changes the backdrop for stocks. Here's what to do next

However, a pair of hot inflation reports and the resulting rise in interest rates represent fresh risks for the market rally ...

Crown Point Energy Inc.: Crown Point Announces Operating and Financial Results for the Three Months Ended March 31, 2026

CWV: Crown Point Energy Inc. ("Crown Point", the "Company", our" or "we - today announced its financial and operating results for the three ...

Assessing Celldex Therapeutics (CLDX) Valuation After Recent Share Price Pullback And Mixed Signals

Celldex Therapeutics stock overview Celldex Therapeutics (CLDX) has been drawing investor attention after recent trading left the stock at a last close of US$32. With no single headline event driving ...